Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus

Introduction. The Global Antiphospholipid Syndrome Score (GAPSS) is a tool proposed to quantify the risk of clinical manifestations associated with antiphospholipid antibodies (aPL) and certain cardiovascular risk factors.Objective. To validate GAPSS in a cohort of patients with systemic lupus eryth...

Full description

Saved in:

Bibliographic Details
Main Authors:	F. A. Cheldieva, T. M. Reshetnyak, A. A. Shumilova, K. S. Nurbaeva, M. V. Cherkasova, A. M. Lila, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2022-11-01
Series:	Научно-практическая ревматология
Subjects:	disease activity antiphospholipid syndrome systemic lupus erythematosus antiphospholipid antibodies thrombosis obstetric pathology
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3221
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)

Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
by: T. M. Reshetnyak
Published: (2017-01-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
by: I. E. Shirokova, et al.
Published: (2003-08-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
by: T. M. Reshetnyak, et al.
Published: (2025-04-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01)

Case Report: Bilateral adrenal hemorrhage in a patient with systemic lupus erythematosus and antiphospholipid syndrome
by: Yuwei Wang, et al.
Published: (2025-08-01)

Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01)

Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use
by: G. M. Tarasova, et al.
Published: (2023-06-01)

Splenic infarcts in a lady with systemic lupus erythematosus and negative antiphospholipid antibodies—A rare case report
by: Amr Ashour, et al.
Published: (2023-03-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01)

ISCHEMIC STROKE IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
by: P. S. Nikitenko, et al.
Published: (2019-07-01)

Assessment of the activity and organ damage in antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2021-08-01)

Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR)
by: T. M. Reshetnyak, et al.
Published: (2024-03-01)

Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome
by: Qing-Nan Zhu, et al.
Published: (2025-08-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

A case of primary antiphospholipid syndrome under the mask of systemic lupus erythematosus
by: N. S. Pozhilenko, et al.
Published: (2022-03-01)

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
by: Z S Alekberova, et al.
Published: (2004-08-01)

Management of systemic lupus erythematosus in pregnancy
by: Oana Denisa Bălălău, et al.
Published: (2022-10-01)

Catastrophic antiphospholipid syndrome: current aspects of pathogenesis, diagnosis and treatment
by: A. A. Klimenko, et al.
Published: (2023-07-01)

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
by: Can Huang, et al.
Published: (2025-01-01)

Retinopathy in a patient with systemic lupus erythematosus
by: Ildefonso Chan, MD, et al.
Published: (2009-12-01)

Pregnancy and its outcome in antiphospholipid syndrome after acute cerebral circulatory failure (clinical case study)
by: T. M. Reshetnyak, et al.
Published: (2024-06-01)

Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)

Clinical significance of the determination of antibodies to the NR2 subunit of glutamate N-methyl-D-aspartate receptors (aNMDAR) in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: T. A. Lisitsyna, et al.
Published: (2025-05-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

Antiphospholipid syndrome presenting as isolated renal vein thrombosis: a case report and review of the literature
by: Khemchand N. Moorani, et al.
Published: (2025-03-01)

Neurological polymorphism of systemic lupus erythematosus
by: A. A. Garmanova, et al.
Published: (2022-03-01)

Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results)
by: K. S. Nurbaeva, et al.
Published: (2023-08-01)

Liver involvement in patients with systemic lupus erythematosus
by: A. P. Panova, et al.
Published: (2021-05-01)

The Potential of Antibodies Against the Phosphatidylserine / Prothrombin Complex as a Biomarker in Antiphospholipid Syndrome
by: Piotr Pasek, et al.
Published: (2025-02-01)